Placenta-based Cell Therapy | Hadassah International

Hadassah International Supports the Hadassah Medical Center: More than a Hospital!

Placental Stem Cell Therapy to Treat Acute Radiation Syndrome Receives Boost from FDA

“Receiving orphan drug designation brings us one step closer to providing a next-generation medical countermeasure against ARS,” notes Zami Aberman, Co-Chief Executive Officer and Chairman of Pluristem. As Pluristem…

Placenta-based Cell Therapy

Placental Stem Cells Prove Successful in Bringing Little Girl to Recovery at Hadassah

Placenta-based Cell Therapy

Placental Cells Found to Have Potential to Mitigate Acute Radiation Syndrome

Bone-marrow (transplantation)

Hadassah-Pluristem Trial Approved for Placental Cell Bone Marrow Regeneration

Cancer Research

Hadassah and Pluristem Report Stem Cells Improve Outcome of Bone Marrow Transplant

Placenta-based Cell Therapy

Leading Developer of Cell Therapy To Collaborate with Hadassah for Safer Transplants

Placenta-based Cell Therapy

Placental Cells Mitigate Radiation-Induced Complications in Mice, Hadassah Researchers Reveal

Bone-marrow (transplantation)

Patient Number Three Saved at Hadassah with World-First Stem Cell Treatment

Bone-marrow (transplantation)

Placental Stem Cell Therapy Saves Hadassah Patient with Bone Marrow Failure